COVID-19 Clinical Trials in Philadelphia

Showing 61-80 of 172 trials

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

NCT04404361

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.

COVID19COVID-19COVID

CTI BioPharma200 participantsStarted May 2020

Orange, California, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +18 more locations

COMPLETEDPhase 317 miles

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

COVID-19SARS-CoV-2

AstraZeneca32,450 participantsStarted Aug 2020

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +81 more locations

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

COVID-19 Trials in Other Cities

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

IMM-BCP-01 in Mild to Moderate COVID-19

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Predictors of Severe COVID-19 Outcomes

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Losmapimod Safety and Efficacy in COVID-19

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

Other Conditions in Philadelphia